Jazayeri Mohammad-Ali, Waheed Salman, Shah Zubair, Parashara Deepak, Gupta Kamal
Department of Cardiovascular Medicine, University of Kansas Medical Center, Kansas City, KS.
Division of Cardiovascular Disease, University of Alabama Birmingham, AL.
Mayo Clin Proc Innov Qual Outcomes. 2019 Oct 22;3(4):409-417. doi: 10.1016/j.mayocpiqo.2019.08.006. eCollection 2019 Dec.
To assess the influence of body-mass index (BMI) on the association of ankle-brachial index (ABI) with mortality.
We conducted a prospective study of National Health and Nutrition Examination Survey participants enrolled from January 1, 1999 to December 31, 2002 with BMI and ABI data available. ABI categories were <0.9 (low), 0.9 to 1.3 (reference), and >1.3 (high). BMI categories were <30 kg/m (nonobese) and ≥30 kg/m (obese). Cardiovascular (CV) and all-cause mortality were assessed by National Death Index records. Cox proportional-hazards models and Kaplan-Meier survival estimates were used to compare groups.
In total, 4614 subjects were included, with mean age 56±12 years and BMI 28±6 kg/m. Median follow-up was 10.3 years (interquartile range [IQR]: 9.3 to 11.4 years). Low and high ABI were present in 7% and 8%, respectively. After adjustment, low ABI was associated with increased all-cause and CV mortality in nonobese (hazard ratio [HR] 1.5, 95% CI, 1.1-2.1 for all-cause and 3.0 [1.8-5.1] for CV mortality) and obese individuals (1.8 [1.2-2.7] and 2.5 [1.2-5.6], respectively) compared with reference. High ABI was associated with increased CV mortality in nonobese (2.2 [1.1-4.5]) but not obese patients; it was not associated with all-cause mortality overall or when stratified by BMI.
In a US cohort, weight influenced the prognostic significance of high ABI. This may be related to technical factors reducing compressibility of the calf arteries in obese persons compared with those who are nonobese.
评估体重指数(BMI)对踝臂指数(ABI)与死亡率之间关联的影响。
我们对1999年1月1日至2002年12月31日纳入的美国国家健康与营养检查调查参与者进行了一项前瞻性研究,这些参与者有可用的BMI和ABI数据。ABI类别为<0.9(低)、0.9至1.3(参考)和>1.3(高)。BMI类别为<30kg/m²(非肥胖)和≥30kg/m²(肥胖)。通过国家死亡指数记录评估心血管(CV)和全因死亡率。使用Cox比例风险模型和Kaplan-Meier生存估计来比较各组。
总共纳入了4614名受试者,平均年龄56±12岁,BMI为28±6kg/m²。中位随访时间为10.3年(四分位间距[IQR]:9.3至11.4年)。低ABI和高ABI分别占7%和8%。调整后,与参考组相比,低ABI与非肥胖个体(全因死亡风险比[HR]1.5,95%CI为1.1 - 2.1;CV死亡风险比为3.0[1.8 - 5.1])和肥胖个体(分别为1.8[1.2 - 2.7]和2.5[1.2 - 5.6])的全因和CV死亡率增加相关。高ABI与非肥胖个体的CV死亡率增加相关(2.2[1.1 - 4.5]),但与肥胖患者无关;总体上它与全因死亡率无关,按BMI分层时也与全因死亡率无关。
在美国队列中,体重影响了高ABI的预后意义。这可能与技术因素有关,与非肥胖者相比,肥胖者小腿动脉的可压缩性降低。